Chemotherapy‐induced peripheral neuropathy (CIPN) has a high prevalence but is poorly
managed for cancer patients due to the lack of reliable and sensitive diagnostic techniques …

Epigenetics is a biological process that modifies and regulates gene expression, affects
neuronal function, and contributes to pain. However, the mechanism by which epigenetics …

Bortezomib is the first-line standard and most effective chemotherapeutic for multiple
myeloma; however, bortezomib-induced peripheral neuropathy (BIPN) severely affects the …

Background No study has quantified the impact of pain and other adverse health outcomes
on global physical and mental health in long-term US testicular cancer survivors or …

Background and aims The transient receptor potential ankyrin 1 (TRPA1) channel has
become a focus in pain research. However, there are no bibliometric studies that …

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most prevalent and dose-
limiting complications in chemotherapy patients. One identified mechanism underlying CIPN …

Focusing on individual patient needs, Cancer Chemotherapy, Immunotherapy and
Biotherapy: Principles and Practice, Seventh Edition, provides thorough, comprehensive …

Development of painful oxaliplatin-induced peripheral neuropathy (OIPN) is a major
problem in people who receive oxaliplatin as part of cancer treatment. The pain experienced …

Phytic acid (PA) has been reported to possess anti-inflammatory and antioxidant properties
that are critical for neuroprotection in neuronal disorders. This raises the question of whether …

Chemotherapy-induced peripheral neuropathy (CIPN) affects approximately 30 to 60% of
people who receive neurotoxic chemotherapy. CIPN is associated with impaired quality of …